Ligustilide: A Phytochemical with Potential in Combating Cancer Development and Progression—A Comprehensive and Critical Review
Year: 2025
Type: article
Abstract: , has garnered attention for its multifaceted pharmacological properties, including anti-inflammatory, neuroprotective, and anticancer effects. This review comprehensively examines Ligustilide and its isomer, (Z)-Ligustilide, focusing on their anticancer potential across various cancer types. Ligustilide exerts its therapeutic effects through multiple mechanisms, including inhibition of cell proliferation, induction of apoptosis, and modulation of autophagy. Additionally, (Z)-Ligustilide has been shown to enhance drug sensitivity and modulate epigenetic regulation, providing a novel approach to overcoming chemoresistance. Despite promising preclinical results, the precise molecular mechanisms, pharmacokinetics, and bioavailability of Ligustilide remain under investigation. Future research should focus on optimizing its therapeutic applications, exploring its synergy with other chemotherapeutic agents, and assessing its potential in personalized cancer therapies. This review offers an in-depth analysis of Ligustilide's anticancer mechanisms, its role in overcoming drug resistance, and its potential as a novel therapeutic strategy in cancer treatment.
Source: Pharmaceuticals
DOI: 10.3390/ph19010036
Authors: Victória Dogani Rodrigues, Mayara Longui Cabrini, Eliana de Souza Bastos Mazuqueli Pereira, Manuela dos Santos Bueno, Virgínia Maria Cavallari Strozze Catharin, Jesselina Francisco dos Santos Haber, Rachel Gomes Eleutério, Lidiane Indiani, Vitor Cavallari Strozze Catharin, Raquel Cristina Ferraroni Sanches, Flávia Cristina Castilho Carácio, Tereza Lais Menegucci Zutin, Vitor Engrácia Valenti, Sandra Maria Barbalho, Lucas Fornari Laurindo
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,499
OpenAlex ID: W7116842306
